In May 2023, Governor Jay Inslee signed Senate Bill 5263 into law, which mandated a study into psilocybin as well as the creation of a regulatory body for the possible recreational and medical use of the drug. This first-of-its-kind study will explore the safety and effectiveness of psilocybin to treat alcohol use disorder (AUD) and for post-traumatic stress disorder (PTSD). Leading the study is Dr. Nathan Sackett, an addiction psychiatrist with the University of Washington’s Department of Psychiatry and Behavioral Sciences.

PsiloStudy is enrolling a small cohort of veterans and first responders who have both alcohol use disorder (AUD) and PTSD to be treated with with psilocybin and psychological support (Psi-PS). Eligible individuals will be in stable general health, willing to undergo psychedelic treatment, and agree to adhere to the treatment protocol – including up to 6 months of follow-up visits. Eligible individuals who finish the study can receive up to $550 for their time. Rigorous screening measures are in place to ensure that it is safe for each person to participate.

This study will be open for recruitment in February 2025.

Check back soon, or sign up for our newsletter to be the first to know.

Webpage updated: February 6th, 2025